Terbinafine 1% cream vs. bifonazole 1% cream in the treatment of tinea cruris

International Journal of Dermatology

Volumn 37, Issue 11, 1998, Pages 871-873

  Budimulja, Unandar ^a  

^a UNIVERSITY OF INDONESIA   (Indonesia)

Author keywords

[No Author keywords available]

Indexed keywords

BIFONAZOLE; TERBINAFINE;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTACT DERMATITIS; COST EFFECTIVENESS ANALYSIS; DISEASE SEVERITY; DRUG EFFICACY; ERYTHEMA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; PAPULE; PATIENT COMPLIANCE; TINEA CRURIS; TOPICAL DRUG ADMINISTRATION; TREATMENT INDICATION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANTIFUNGAL AGENTS; DERMATITIS, CONTACT; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMIDAZOLES; MALE; MIDDLE AGED; NAPHTHALENES; OINTMENTS; PATIENT DROPOUTS; RECURRENCE; SKIN; TREATMENT OUTCOME;

EID: 0031729031     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-4362.1998.00588.x     Document Type: Article

References (3)

1. Sud IJ, Feingold DS. Mechanisms of action of antimycotic imidazoles. J Invest Dermatol 1981; 76: 438-441.
2. Cordero C, DeLaRosa I, Espinoza Z, Zaias N. Shortterm therapy of tinea cruris/corporis with topical terbinafine. J Dermatol Ther 1992; (Suppl. 1); 23-24.
3. Evans EGV, Shah JM, Joshipura RC. One-week treatment of tinea corporis and tinea cruris with terbinafme 1% cream: a placebo controlled study. J Dermatol Ther 1992.; 1: 181-184.